Comparison of Lymphocyte–CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19

Background: In COVID-19 patients, lymphocyte–CRP ratio (LCR) is a promising biomarker for predicting adverse clinical outcomes. How well LCR performs compared to conventional inflammatory markers for prognosticating COVID-19 patients remains unclear, which hinders the clinical translation of this no...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Alexander, Hammond, Robert, Chan, Kenneth, Chukwuenweniwe, Chukwugozie, Johnson, Rebecca, Khair, Duaa, Duck, Eleanor, Olubodun, Oluwaseun, Barwick, Kristian, Banya, Winston, Stirrup, James, Donnelly, Peter D., Kaski, Juan Carlos, Coates, Anthony R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301623/
https://www.ncbi.nlm.nih.gov/pubmed/37373898
http://dx.doi.org/10.3390/jpm13060909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301623/
https://www.ncbi.nlm.nih.gov/pubmed/37373898
http://dx.doi.org/10.3390/jpm13060909

Ejemplares similares